MyMedR

Displaying all 7 publications

Abstract:

Sort:

Fulltext Swiftlets and edible bird’s nest industry in Asia

Looi, Qi Hao, Abdul Rahman Omar

The Pertanika Journal of Scholarly Research Reviews, 2016;2(1):32-48.
MyJurnal

Swiftlet
s
are small insectivorous birds which breed throughout Southeast Asia and
the South Pacific.
Among many swiftle
t species, only a few are notable to produce edible bird’s
nest
s
(EBN) from the secreted saliva during breeding seasons.
The taxonomy of swiftlet
s
remains one of the most controversial in the avian species due to the high similarity in
morphological charac
teristics among the species. Over the last few decades, researchers have
studied the taxonomy of swiftlet
s
based on the morphological
trade
, behavior, and genetic
traits
.
However, despite all the efforts,
the
swiftlet taxonomy remains unsolved.
The
EBN is one of
the
most expensive animal products
and frequently being referred
to
as the “
Caviar of the East
”.
The
EBN market value varies from
US
$1000.00 to
US
$10,000.00 per kilogram depend
ing
on
its grade, shape, type and origin.
Hence, bird’s nest harve
sting is considered a lucrative industry
in many countries in Southeast Asia.
However,
the
industry faced several challenges over the
decades such as the authenticity of the EBN, the quality assurance and the depletion of swiftlet
population. Furthermore,
there is limited scientific evidence regarding EBN’s medical benefits
as
claimed by manufacturers. This paper reviews the taxonomy of swiftlet
s
, its morphological
characteristics, the challenges currently encountered by the industry, and finally the
compos
ition and medical benefits of EBN.
Fulltext Treatment of spinal cord injury with mesenchymal stem cells

Liau LL, Looi QH, Chia WC, Subramaniam T, Ng MH, Law JX

Cell Biosci, 2020;10:112.
PMID: 32983406 DOI: 10.1186/s13578-020-00475-3

Background: Spinal cord injury (SCI) is the damage to the spinal cord that can lead to temporary or permanent loss of function due to injury to the nerve. The SCI patients are often associated with poor quality of life.
Results: This review discusses the current status of mesenchymal stem cell (MSC) therapy for SCI, criteria to considering for the application of MSC therapy and novel biological therapies that can be applied together with MSCs to enhance its efficacy. Bone marrow-derived MSCs (BMSCs), umbilical cord-derived MSCs (UC-MSCs) and adipose tissue-derived MSCs (ADSCs) have been trialed for the treatment of SCI. Application of MSCs may minimize secondary injury to the spinal cord and protect the neural elements that survived the initial mechanical insult by suppressing the inflammation. Additionally, MSCs have been shown to differentiate into neuron-like cells and stimulate neural stem cell proliferation to rebuild the damaged nerve tissue.
Conclusion: These characteristics are crucial for the restoration of spinal cord function upon SCI as damaged cord has limited regenerative capacity and it is also something that cannot be achieved by pharmacological and physiotherapy interventions. New biological therapies including stem cell secretome therapy, immunotherapy and scaffolds can be combined with MSC therapy to enhance its therapeutic effects.
How far have we reached in development of effective influenza vaccine?

Looi QH, Foo JB, Lim MT, Le CF, Show PL

Int Rev Immunol, 2018;37(5):266-276.
PMID: 30252547 DOI: 10.1080/08830185.2018.1500570

Despite of ongoing research programs and numerous clinical trials, seasonal influenza epidemics remain a major concern globally. Vaccination remains the most effective method to prevent influenza infection. However, current flu vaccines have several limitations, including limited vaccine capacity, long production times, inconsistence efficacy in certain populations, and lack of a "universal" solution. Different next-generation approaches such as cell line-based culture, reverse genetics, and virus expression technology are currently under development to address the aforementioned challenges in conventional vaccine manufacture pipeline. Such approaches hope for safe and scalable production, induce broad-spectrum immunity, create premade libraries of vaccine strains, and target nonvariable regions of antigenic proteins for "universal" vaccination. Here, we discuss the process and challenges of the current influenza vaccine platform as well as new approaches that are being investigated. These developments indicate that an exciting future lies ahead in the influenza vaccine field.
Fulltext The Potential of Mesenchymal Stromal Cell as Therapy in Neonatal Diseases

Liau LL, Al-Masawa ME, Koh B, Looi QH, Foo JB, Lee SH, et al.

Front Pediatr, 2020;8:591693.
PMID: 33251167 DOI: 10.3389/fped.2020.591693

Mesenchymal stromal cells (MSCs) can be derived from various tissue sources, such as the bone marrow (BMSCs), adipose tissue (ADSCs), umbilical cord (UC-MSCs) and umbilical cord blood (UCB-MSCs). Clinical trials have been conducted to investigate the potential of MSCs in ameliorating neonatal diseases, including bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH) and necrotizing enterocolitis (NEC). In preclinical studies, MSC therapy has been tested for the treatment of various neonatal diseases affecting the heart, eye, gut, and brain as well as sepsis. Up to date, the number of clinical trials using MSCs to treat neonatal diseases is still limited. The data reported thus far positioned MSC therapy as safe with positive outcomes. However, most of these trials are still preliminary and generally smaller in scale. Larger trials with more appropriate controls and a longer follow-up period need to be conducted to prove the safety and efficacy of the therapy more conclusively. This review discusses the current application of MSCs in treating neonatal diseases, its mechanism of action and future direction of this novel therapy, including the potential of using MSC-derived extracellular vesicles instead of the cells to treat various clinical conditions in the newborn.
Benchtop Isolation and Characterisation of Small Extracellular Vesicles from Human Mesenchymal Stem Cells

Tan KL, Chia WC, How CW, Tor YS, Show PL, Looi QHD, et al.

Mol Biotechnol, 2021 Sep;63(9):780-791.
PMID: 34061307 DOI: 10.1007/s12033-021-00339-2

The objective of this study is to develop a simple protocol to isolate and characterise small extracellular vesicles (sEVs) from human umbilical cord-derived MSCs (hUC-MSCs). hUC-MSCs were characterised through analysis of morphology, immunophenotyping and multidifferentiation ability. SEVs were successfully isolated by ultrafiltration from the conditioned medium of hUC-MSCs. The sEVs' size distribution, intensity within a specific surface marker population were measured with zetasizer or nanoparticle tracking analysis. The expression of surface and internal markers of sEVs was also assessed by western blotting. Morphology of hUC-MSCs displayed as spindle-shaped, fibroblast-like adherent cells. Phenotypic analysis by flow cytometry revealed that hUC-MSCs expressed MSC surface marker, including CD90, CD73, CD105, CD44 and exhibited the capacity for osteogenic, adipogenic and chondrogenic differentiation. Populations of sEVs with CD9, CD63 and CD81 positive were detected with size distribution in the diameter of 63.2 to 162.5 nm. Typical sEVs biomarkers such as CD9, CD63, CD81, HSP70 and TSG101 were also detected with western blotting. Our study showed that sEVs from hUC-MSCs conditioned medium were successfully isolated and characterised. Downstream application of hUC-MSCs-sEVs will be further explored.
Skin lightening properties of zerumbone cream: A placebo-controlled study

Kuek WN, Tiang YR, Yow HY, Tan LKS, How CW, Looi QHD, et al.

J Cosmet Dermatol, 2024 Jun;23(6):2117-2124.
PMID: 38366687 DOI: 10.1111/jocd.16234

OBJECTIVE: Despite the demonstrated anti-melanogenic and UV protective effects of Zerumbone (ZER) in vitro, there is a lack of clinical trials that have been done to assess these properties. The primary objective of this study was to assess the effectiveness of ZER in lightening the skin tone of human participants with a single-blind approach.
METHODS: Twenty-six participants were randomly assigned to two groups to investigate the application location (left or right volar forearm) for the placebo and ZER creams. Both creams were topically administered to the volar forearms twice daily over a duration of 4 weeks. Initial skin irritation was assessed before and 30 min after applying creams. The melanin and erythema levels were quantified with Mexameter MX 18.
RESULTS: Twenty participants were included in the analysis. The cream formulation had excellent physical properties and was well-received by the participants. The initial skin irritation study results indicated that neither of the creams elicited an allergic reaction. The administration of ZER cream resulted in a statistically significant reduction in melanin levels (p
Fulltext Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine

Foo JB, Looi QH, Chong PP, Hassan NH, Yeo GEC, Ng CY, et al.

Stem Cells Int, 2021;2021:2616807.
PMID: 34422061 DOI: 10.1155/2021/2616807

Cell therapy involves the transplantation of human cells to replace or repair the damaged tissues and modulate the mechanisms underlying disease initiation and progression in the body. Nowadays, many different types of cell-based therapy are developed and used to treat a variety of diseases. In the past decade, cell-free therapy has emerged as a novel approach in regenerative medicine after the discovery that the transplanted cells exerted their therapeutic effect mainly through the secretion of paracrine factors. More and more evidence showed that stem cell-derived secretome, i.e., growth factors, cytokines, and extracellular vesicles, can repair the injured tissues as effectively as the cells. This finding has spurred a new idea to employ secretome in regenerative medicine. Despite that, will cell-free therapy slowly replace cell therapy in the future? Or are these two modes of treatment still needed to address different diseases and conditions? This review provides an indepth discussion about the values of stem cells and secretome in regenerative medicine. In addition, the safety, efficacy, advantages, and disadvantages of using these two modes of treatment in regenerative medicine are also critically reviewed.